PLK1 and nonpapillary renal cell carcinoma: Besides, HIF-2 transcriptionally targeted the hypoxia response element on the Polo-like kinase 1 (Plk1) promoter, which promoted Plk1 expression in ccRCC, leading to ccRCC growth, metastasis, and drug resistance (Dufies et al., 2021).